Long-Term Outcomes of Salvage Stereotactic Ablation Radiotherapy for Isolated Lung Recurrence of Non-Small-Cell Lung Cancer: A Phase II Clinical Trial

OBJECTIVES: Our goal was to evaluate stereotactic ablative radiotherapy (SABR) as a salvage option for isolated recurrence of non-small-cell lung cancer (NSCLC) in the lung parenchyma following definitive treatment of stage I-III disease. METHODS: Patients who had histologically confirmed, positron...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Thorac Oncol
Autores principales: Sun, Bing, Brooks, Eric D., Komaki, Ritsuko, Liao, Zhongxing, Jeter, Melenda, McAleer, Mary, Balter, Peter A., Welsh, James D., O’Reilly, Michael, Gomez, Daniel, Hahn, Stephen. M., Sepesi, Boris, Rice, David C., Heymach, John V., Chang, Joe Y.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2017
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5881570/
https://ncbi.nlm.nih.gov/pubmed/28259750
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtho.2017.02.018
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares